HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES: PERSPECTIVES OF THE PATIENTS AND CAREGIVERS

被引：0
|
作者：
Yang, Xiaoqin [1 ]
Yoo, Hyun Kyoo [2 ]
Amin, Suvina [3 ]
Cheng, Wendy [4 ]
Sipsma, Heather [4 ]
Sundaresan, Sanjana [4 ]
Zhang, Lujia [4 ]
Duh, Mei Sheng [4 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Gaithersburg, MD USA
[4] Analysis Grp, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
QOLP-02
引用
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [1] Health-related quality of life (HRQoL) among pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibroma (PN) in the United States (US).
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy Y.
    Sipsma, Heather
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei Sheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study
    Xiaoqin Yang
    Hyun Kyoo Yoo
    Suvina Amin
    Wendy Y. Cheng
    Sanjana Sundaresan
    Lujia Zhang
    Mei S. Duh
    [J]. Neurology and Therapy, 2022, 11 : 1221 - 1233
  • [3] Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy Y.
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei S.
    [J]. NEUROLOGY AND THERAPY, 2022, 11 (03) : 1221 - 1233
  • [4] CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US)
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy
    Sipsma, Heather
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei Sheng
    [J]. NEURO-ONCOLOGY, 2021, 23 : 41 - 42
  • [5] PREDICTORS OF PLEXIFORM NEUROFIBROMA (PN) GROWTH IN PATIENTS WITH NEUROFIBROMATOSIS 1 (NF1)
    Akshintala, Srivandana
    Dombi, Eva
    Baldwin, Andrea
    Gillespie, Andy
    Goodspeed, Wendy
    Goodwin, Anne
    Whitcomb, Patricia
    Steinberg, Seth
    Widemann, Brigitte
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S32 - S33
  • [6] Health-Related Quality of Life in Patients with Neurofibromatosis Type 1
    Kodra, Yllka
    Giustini, Sandra
    Divona, Luigina
    Porciello, Roberto
    Calvieri, Stefano
    Wolkenstein, Pierre
    Taruscio, Domenica
    [J]. DERMATOLOGY, 2009, 218 (03) : 215 - 220
  • [7] A phase I study of thalidomide for the treatment of plexiform neurofibroma in patients with neurofibromatosis 1 (NF1)
    Gupta, A
    Cohen, BH
    Ruggieri, P
    Packer, RJ
    Phillips, P
    [J]. NEUROLOGY, 2000, 54 (07) : A12 - A13
  • [8] Access to Specialized Neurofibromatosis Clinics in the United States: A National Survey of Neurofibromatosis 1 (NF1) Patients and Caregivers
    Merker, Vanessa L.
    Ma, Yidan
    Chibnik, Lori B.
    Ullrich, Nicole J.
    Yohay, Kaleb H.
    Knight, Pamela
    Radtke, Heather B.
    Plotkin, Scott R.
    Jordan, Justin T.
    [J]. ANNALS OF NEUROLOGY, 2022, 92 : S104 - S104
  • [9] Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA
    Xiaoqin Yang
    Hyun Kyoo Yoo
    Suvina Amin
    Wendy Y. Cheng
    Sanjana Sundaresan
    Lujia Zhang
    Mei Sheng Duh
    [J]. Child's Nervous System, 2022, 38 : 1513 - 1522
  • [10] Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy Y.
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei Sheng
    [J]. CHILDS NERVOUS SYSTEM, 2022, 38 (08) : 1513 - 1522
12345